Filter content

atai Life Sciences, a clinical-stage biopharmaceutical firm backed by Peter Thiel and other investors, recently acquired a majority stake in Recognify Life Sciences. Recognify is developing a treatment for cognitive impairment associated with schizophrenia (CIAS). Its lead compound has…

The proposal by Philadelphia not-for-profit Safehouse to open the first supervised injection facility in the United States has hit a roadblock after a U.S. Circuit Court of Appeals ruled, 2-1, that doing so would violate federal law.

Broadstep Behavioral Health has acquired Excalibur Youth Services, which operates six facilities in South Carolina. Broadstep, which moved its headquarters from Wisconsin to North Carolina last year, provides resident and community-based services for individuals with intellectual, developmental…

Prescription digital therapeutics firm Pear Therapeutics and Groups Recover Together, an outpatient opioid use disorder treatment provider with operations in eight states, have announced a partnership to deliver their respective services together in Indiana. The deal will pair Groups’ clinical,…

PCPs are often told they do not prescribe as well as psychiatrists nor modify patient behavior as well as psychotherapists. On the other hand, behavioral healthcare professionals typically lack the abiding commitment of PCPs to both body and mind. Psychiatrists focus largely on biology, therapists…

Community Psychiatry, a Sacramento, California-based provider of outpatient behavioral health services, announced that it has appointed J. Christopher Brengard as its CEO. The company is also expanding its board of directors to add experience in the areas of public policy and payer relations.…

The Foundation for Opioid Response Efforts, a private, not-for-profit grantmaking organization that funds projects to address the opioid crisis at national, state and community levels, has announced the creation of its Scientific Advisory Council. The seven-person panel will advise FORE’s board of…

Mind Cure Health, a Vancouver, British Columbia-based mental health firm, announced this week that it has signed a letter of intent to acquire an ownership interest in ATMA Journey Centers, a Calgary, Alberta-based treatment center that provides psychedelic-assisted therapy for patients who qualify…

London-based COMPASS Pathways and the Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore announced that the two organizations are collaborating on a “Centre of Excellence” that will serve as a research facility and innovation lab for the development of mental healthcare…